- Home
- CBFV vs TLSI Comparison
CBFV vs TLSI Comparison
Compare CBFV & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBFV
- TLSI
- Stock Information
- Founded
- CBFV 1901
- TLSI 2010
- Country
- CBFV United States
- TLSI United States
- Employees
- CBFV N/A
- TLSI N/A
- Industry
- CBFV Major Banks
- TLSI Medical Specialities
- Sector
- CBFV Finance
- TLSI Health Care
- Exchange
- CBFV Nasdaq
- TLSI Nasdaq
- Market Cap
- CBFV 148.0M
- TLSI 160.4M
- IPO Year
- CBFV N/A
- TLSI N/A
- Fundamental
- Price
- CBFV $28.45
- TLSI $5.52
- Analyst Decision
- CBFV Hold
- TLSI Strong Buy
- Analyst Count
- CBFV 2
- TLSI 6
- Target Price
- CBFV $26.00
- TLSI $11.75
- AVG Volume (30 Days)
- CBFV 20.2K
- TLSI 67.6K
- Earning Date
- CBFV 04-25-2025
- TLSI 03-27-2025
- Dividend Yield
- CBFV 3.48%
- TLSI N/A
- EPS Growth
- CBFV N/A
- TLSI N/A
- EPS
- CBFV 2.38
- TLSI N/A
- Revenue
- CBFV $50,028,000.00
- TLSI $29,431,000.00
- Revenue This Year
- CBFV $8.55
- TLSI $55.43
- Revenue Next Year
- CBFV $9.01
- TLSI $50.09
- P/E Ratio
- CBFV $12.08
- TLSI N/A
- Revenue Growth
- CBFV N/A
- TLSI 58.99
- 52 Week Low
- CBFV $20.75
- TLSI $3.50
- 52 Week High
- CBFV $33.72
- TLSI $10.42
- Technical
- Relative Strength Index (RSI)
- CBFV 49.27
- TLSI 52.49
- Support Level
- CBFV $27.86
- TLSI $5.23
- Resistance Level
- CBFV $29.59
- TLSI $5.72
- Average True Range (ATR)
- CBFV 0.68
- TLSI 0.35
- MACD
- CBFV 0.14
- TLSI 0.02
- Stochastic Oscillator
- CBFV 55.12
- TLSI 78.72
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.